earnings
confidence high
sentiment positive
materiality 0.70
cbdMD Q4 net sales up 3-5% YoY; FY net loss improves to ~$2M from $3.7M
cbdMD, Inc.
2025-FY EPS reported
-$1.09
revenue$19,190,468
- Net sales for fiscal 2025 expected $19.1–19.3M vs $19.5M prior year.
- Q4 net sales expected $4.7–4.9M, up 3-5% from $4.6M in Q4 2024.
- Net loss for fiscal 2025 improved to $1.9–2.1M from $3.7M in fiscal 2024.
- CEO cites disciplined cost management and positive sequential revenue growth.
- Full earnings call scheduled for mid-December 2025.